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Abstract: A 4-year-old castrated male Korean domestic shorthair cat was referred with bilateral corneal edema. Focal and generalized
acute bullous keratopathy in the oculus dexter and oculus sinister, respectively, were diagnosed by ophthalmologic examinations.
Intensive topical treatment was administered to both eyes. A therapeutic soft contact lens was inserted in the oculus sinister as a corneal
bandage instead of surgical treatment. The patient achieved complete recovery at 44 days after treatment. A therapeutic soft contact lens
and an intensive regimen involving a topical hyperosmotic solution successfully treated acute bullous keratopathy in a feline patient.
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1. Introduction
Feline acute bullous keratopathy (ABK), also known
as feline acute corneal hydrops, is characterized by
the development of subepithelial bullae in the cornea
(1,2). A single bulla or multiple bullae may develop
rapidly (within 24–48 h); multiple bullae can merge
into a single large bulla, rupture, and cause eye loss
(2–4). This condition initially appears unilaterally and
later becomes bilateral (4). In addition, edema affects a
corneal area ranging in diameter from a few millimeters
to the entire cornea (1).
ABK is diagnosed according to the clinical
presentation and ophthalmologic examination findings
and must be differentiated from corneal melting
ulcers, descemetoceles, corneal sequestra, trauma,
and lacerations (4). Currently, the treatment of ABK
involves procedures that deliver mechanical pressure to
the bulla (1). The most common treatment protocol for
ABK incorporates surgical treatment, such as superficial
keratectomy, nictitating membrane flap, temporary
tarsorrhaphy, conjunctival grafting, amniotic membrane
transplantation, or perforating keratoplasty surgically,
as well as medical treatment, such as topical antibiotic
or hyperosmotic sodium chloride therapy (1,2,5).
More recently, physical devices such as therapeutic
soft contact lenses (TSCLs) have been used as bandages

to protect the cornea (6). In the fields of human and
veterinary medicine, TSCLs have been used to provide
pain relief, mechanical protection, and structural
support while promoting epithelial healing, maintaining
hydration, and delivering medication (5,6). A previous
study of human medicine described the frequent use
of TSCLs as bandages that could facilitate corneal
reepithelialization (7). Before 1971, contact lenses had
already been used to treat human patients with bullous
keratopathy; in particular, these lenses provided pain
relief by separating the bullae from the lids (5,8).
The endothelial and epithelial borders of the
cornea form a barrier that controls the flow of water
and maintains hydration homeostasis via an active
pump mechanism (9). Many processes, such as
inflammation, trauma, degenerative disease, toxins, or
surgical procedures, can promote the loss of corneal
transparency (10). Currently, topical hyperosmotic
agents are frequently used to relieve corneal edema (6).
A hyperosmotic 5% NaCl solution is most commonly
used and has been reported to relieve symptoms
effectively (10).
This case report describes successful use of a TSCL
and intensive topical hyperosmotic solution (rather than
surgical treatment such as tarsorrhaphy or keratectomy)
to treat ABK in a cat.
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2. Case history
A 4-year-old castrated male Korean domestic shorthair
cat with corneal edema was referred to the Yoolim Animal
Clinic. The referring veterinarian had observed this
corneal edema for 3 days and had first diagnosed corneal
edema in the oculus sinister (OS), followed by the oculus
dexter (OD). The cat had undergone tarsorrhaphy of the
OS at the referring veterinary hospital 1 day earlier, and
this procedure involved a ribbon-shaped knot that could
be released temporarily to allow examination and medical
treatment. The patient was placed in an Elizabethan collar
to prevent self-injury.
Ophthalmologic and physical examinations of the
OS were performed after the temporary release of the
tarsorrhaphy knot. Despite photophobia, vision retention
was confirmed through a visual test. The macroscopic
examination revealed bilateral conjunctival hyperemia
with focal corneal edema of the OD (Figure 1A) and
generalized edema of the OS (Figure 1B). A slit lamp

examination (SL-D7, Topcon Corp., Tokyo, Japan)
identified bullae between the corneal epithelium and
stroma (Figures 1C and D). The intraocular pressure (Icare
TONOVET; Icare, Vantaa, Finland) in both eyes was 12
mmHg. Fluorescein staining revealed a corneal ulcer in
the OS. Generalized corneal edema in the OS prevented
additional ophthalmologic examination. No remarkable
findings other than focal edema were observed in the OD.
Accordingly, a diagnosis of bilateral ABK was made.
3. Results and discussion
The patient was calm and tolerated both the examination
and medical therapy. The latter involved the application
of topical ofloxacin (Ocuflox eye drops; Samil, Seoul,
Korea), and 5% NaCl at a dose of 1 drop every 6 h to the
OD; tarsorrhaphy of the OS was maintained except during
examination and medication (initial treatment on day 0).
Macroscopic and slit lamp examinations performed 1 day
after treatment initiation revealed that the bulla in the OD

Figure 1. Appearance of bilateral acute bullous keratopathy in a 4-year-old castrated male Korean domestic shorthair cat at the initial
presentation. (A) Macroscopic examination revealed focal edema and conjunctival hyperemia in the OD. (B) Macroscopic examination
revealed generalized corneal edema and conjunctival hyperemia in the OS. The purple thread from the released tarsorrhaphy is visible.
(C) Slit lamp examination revealed focal bullous edema between the corneal stroma in the OD. (D) Slit lamp examination revealed
generalized bullous edema in the OS. Again, the tarsorrhaphy thread is visible.
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had decreased (Figures 2A and 2C), whereas the bulla in
the OS remained unchanged (Figures 2B and 2D). After
removing the tarsorrhaphy, the TSCL margin (Acrivet
Pat D1; Acrivet Inc., Berlin, Germany) was inserted into
the deep conjunctiva of the OS to cover the whole bulla
without artificial contouring, and intensive medical
therapy comprising topical ofloxacin every 6 h and 5%
NaCl (1 drop every 1 h) was administered. The TSCL
was removed during each ophthalmologic examination
and replaced after examination. At 2 days after the initial
treatment, the topical treatment regimen for the OD
was reduced to every 12 h following the observation of
improvements; however, a slit lamp examination revealed
that the bulla had not disappeared completely (Figures
3A and 3C). Improved photophobia was observed on the
same day, and a fluorescein staining test failed to detect the
corneal ulcer in the OS (Figures 3B and 3D).
Eleven days after treatment initiation, the topical
treatments were terminated in the OD once a slit lamp
examination confirmed resolution of the bulla (Figures 4A

and 4C). The bulla in the OS, although still present, had
diminished (Figures 4B and 4D), and topical treatments
were tapered to every 6 h. Treatment of the OS was
terminated 44 days after initiation because the bulla had
disappeared completely (Figures 5A and 5B). The TSCL
remained on the OS except during examinations and was
removed simultaneously with the termination of topical
treatment. No recurrence was observed during a 6-month
follow-up.
Although there have been reports on the use of
corneal lenses in feline, canine, and human ABK (5,11),
occurrence of ABK is rare in feline species and progresses
more rapidly in cats than in dogs (12). ABK in the feline
cornea can be compared with keratoconus in the human
cornea, a progressive and noninflammatory condition
that causes the corneal surface to form a corn shape (2).
The etiology of feline ABK is unknown, although clinical
and histopathological findings suggest that the condition
is associated with stromal and/or endothelial dystrophy
(1,11–13). The corneal stromal fluid is mainly controlled

Figure 2. Appearance of the eyes at 1 day after the initial treatment. Bullous edema was diminished in the OD but unchanged in the
OS. (A) Macroscopic examination revealed diminished focal edema in the OD. (B) Macroscopic examination revealed no change in the
bulla in the OS. The purple thread from the released tarsorrhaphy is visible. (C) Slit lamp examination revealed edema in the OD. (D)
Slit lamp examination revealed a generalized bulla in the OS. Again, the tarsorrhaphy thread is visible.
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Figure 3. Appearance of the eyes at 2 days after the initial treatment. (A) Macroscopic examination did not detect edema in the OD. (B)
Macroscopic examination did not observe a change in the size of the bulla in the OS. (C) Slit lamp examination revealed only a slight
bulla in the cornea of the OD. (D) Slit lamp examination revealed no change in the bulla in the OS.

by the endothelium, which pumps solutes from the stroma
to the aqueous humor; the epithelium plays a lesser role
by pumping solutes from the stroma to the tears (6). The
normal corneal stroma is maintained in a state of 78%
hydration (9). In canine species, ABK has been attributed
to corneal endothelium abnormalities that affect fluid and
solute transport control and result in a dehydrated stroma.
These phenomena are associated with various congenital
and acquired diseases such as breed-related and age-related
endothelial diseases, uveitis, glaucoma, toxic injuries,
melting keratitis, trauma (self or other), collagenolytic
ulceration, and hereditary dystrophy, as observed in Manx
cats with induced corneal edema. Damage to endothelial
cells because of phacoemulsification after cataract surgery
has also been reported to cause ABK or pseudophakic BK
in this context (2,7).
Generally, the treatments recommended for ABK
involve administration of corneal pressure via temporary
tarsorrhaphy, a conjunctival flap, or a nictitating membrane
flap (1,2,6,11). Penetrating keratoplasty may be applied
to replace dysfunctional endothelial cells and stromal
layers; however, this procedure is not performed routinely

because of costs, the risk of corneal allograft rejection,
and the inconvenience of immunosuppressive medication
regimens. Moreover, surgical expertise and specialized
equipment are needed to apply penetrating keratoplasty
(14). Various other therapies have also been described. For
example, Hansen et al. described the application of frozen
lamellar corneal grafts to two feline patients with ABK (4).
In human patients, TSCL application has been
described as a treatment option prior to a conjunctival flap
procedure or amniotic membrane transplantation (2,15).
TSCLs have frequently been used alone or in combination
with partial tarsorrhaphy to provide corneal protection
(5,6,12). TSCLs also apply pressure to and thereby
immobilize the corneal bulla, thus stabilizing corneal pain
and protecting the bulla from conjunctival stimulation.
Moreover, TSCLs have been reported to retain some
topically applied drugs on the eyes, a phenomenon as
known as the depot effect (6).
However, a TSCL treatment without concomitant
therapy was not found to improve corneal edema (10).
Topical broad-spectrum antibiotics and hyperosmotic
solutions have been recommended for the medical
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Figure 4. Appearance of the eyes at 11 days after the initial treatment. Bullous edema was not observed in the OD. (A) Macroscopic
examination revealed no bulla in the OD. (B) Macroscopic examination revealed reduced edema in the OS. (C) Slit lamp examination
of the OD revealed no bulla in the cornea. (D) Slit lamp examination detected remaining edema in the OS.

Figure 5. Appearance of the eyes at 44 days after the initial treatment. The bullous edema disappeared completely from OU. (A) OD,
(B) OS.

treatment of ABK (1). The human medical literature
describes the administration of hyperosmotic solutions
as essential and reports that the application of a TSCL
in the absence of hypertonic solutions failed to improve
corneal edema. Although an optimal dose has not yet been
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established in human medicine, the recommended dose of
a hypertonic solution is 1–2 drops given 4–6 times per day
(10); in veterinary medicine, treatment is recommended at
least 4 times daily because of the time required to affect the
tear osmolality (6). The cornea comprises semipermeable
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layers and thus exchanges fluid from the anterior chambers
and tears. A 5% NaCl solution for corneal dehydration
remained effective for more than 1 h, and to replenish
the NaCl lost via the tears, the solution was applied at
intervals of 1 h (9). Moreover, Knezović et al. reported
that treatment with a 5% NaCl solution was significantly
effective for early-stage ABK (10). Additionally, the use of
topical corticosteroids remains controversial (7,14), and
a recent report demonstrated that systemic cyclosporine
administration could be a risk factor for ABK in felines
(13).
In this case, we chose to use a TSCL as a corneal bandage
for several reasons. Tarsorrhaphy did not appear to have
reduced the bulla after 2 days and presented a barrier to
intensive treatment with topical solutions. In addition, a
TSCL might cause a sustained release effect, thus increasing
the time of contact with topical solutions and thus the
cornea-drug retention time. Moreover, to maintain the
hyperosmotic solution concentration, we initially applied
the solution every hour. Because the patient’s vision was
restricted during flap treatments or tarsorrhaphy of both
eyes, intensive topical medications were administered only
for focal edema in the OD and in association with a TSCL,
which provided pressure, for general edema in the OS.
The treatment duration was shorter than that associated
with a conjunctival graft in a feline patient with ABK, and
application of the TSCL during treatment not only allowed

the patient to retain vision but also allowed convenient
monitoring of the corneas by veterinarians.
ABK may cause pain related to an irritated or stretched
corneal nerve, exposure of the corneal nerve ending,
acute epithelial swelling, or disruption by edema (7,8).
These types of pain are evidenced by symptoms such as
epiphora, photophobia, and blepharospasm (5,8). Previous
studies of therapeutic contact lenses mentioned their role
as a precorneal protective layer that helps to protect the
abnormal epithelium from external noxious stimuli; notably,
patients with bullous keratopathy tend to experience nearimmediate pain relief following TSCL application (8). In
the present case, we believe that the patient experienced
pain relief, as the observed photophobia disappeared along
with the corneal ulcer within 1 day of TSCL application.
In conclusion, intensive application of a topical
hyperosmotic solution together with a TSCL was used
to treat ABK successfully in a feline patient; accordingly,
the patient did not require concurrent or subsequent
surgical treatment. To investigate the effect of intensive
hyperosmotic medication with a TSCL, further cases and
research are needed.
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